Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about APLS

Recent news which mentions APLS

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Why Is Biogen Stock Falling Thursday?
Tickers APLS BIIB IONS NEWS
Tags Large Cap why it's moving IONS
From Benzinga
Biogen Stock Gains Despite Extended FDA Review For Alzheimer&#39;s Therapy
Tickers APLS BIIB NEWS
Tags News Health Care Large Cap
From Benzinga
Top 3 Health Care Stocks That May Collapse This Month
Tickers APLS AVNS CERS NEWS
Tags Benzinga Markets Pre/Market Outlook
From Benzinga
Roblox, Carvana, eBay, C.H. Robinson Worldwide, Huntington Ingalls Industries And Other Big Stocks Moving Higher On Thursday
Tickers AGCO ALNY AMSC APLD
Tags HII ALNY Benzinga
From Benzinga
Earnings Scheduled For July 31, 2025
Tickers AAMI AAPL ABBV ACCO
Tags DTM AAMI MTZ
From Benzinga
FDA Approval For Empaveli Marks Key Milestone In Apellis' Rare Disease Portfolio
Tickers APLS NEWS
Tags Analyst Color Expert Ideas why it's moving
From Benzinga
Apellis Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (15 Ratings)
Tickers APLS
Tags APLS BZI/AAR Market News
From Benzinga
What 13 Analyst Ratings Have To Say About Apellis Pharmaceuticals
Tickers APLS
Tags APLS Benzinga Market News
From Benzinga
Expert Outlook: Apellis Pharmaceuticals Through The Eyes Of 17 Analysts
Tickers APLS
Tags Analyst Ratings Market News BZI/AAR
From Benzinga
Why Apellis Pharmaceuticals Wilted on Wednesday
Tickers APLS
Tags APLS ^GSPC Market News
From Motley Fool
Sarepta Therapeutics, Mercury Systems, Arista Networks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Tickers ANET APLS HCKT LNTH
Tags Benzinga Markets RXO
From Benzinga
Earnings Scheduled For May 7, 2025
Tickers ACAD ACDC ACRE ACVA
Tags TECH BROS VIR
From Benzinga
Apellis Pharmaceuticals's Earnings Outlook
Tickers APLS
Tags Market News Benzinga Earnings
From Benzinga
What 9 Analyst Ratings Have To Say About Apellis Pharmaceuticals
Tickers APLS
Tags Analyst Ratings Benzinga Market News
From Benzinga
FDA Reviews Kidney Disease Drug From Apellis Pharmaceuticals
Tickers APLS NEWS NVS
Tags Food and Drug Administration (FDA) Movers Benzinga
From Benzinga
JP Morgan Cut Apellis' Price Forecasts, Cites Longer Peak Sales Timing For Syfovre
Tickers ALPMF ALPMY APLS NEWS
Tags ALPMY Analyst Color Expert Ideas
From Benzinga
Apellis Lead Drug Pegcetacoplan Represents Differentiated Asset: JP Morgan Analyst
Tickers APLS NEWS
Tags Movers Benzinga Biotech
From Benzinga
Breaking Down Apellis Pharmaceuticals: 6 Analysts Share Their Views
Tickers APLS
Tags Market News BZI/AAR Benzinga
From Benzinga
Earnings Scheduled For February 28, 2025
Tickers AMR AMRX ANIP APLS
Tags BFLY OMI AMR
From Benzinga
What 6 Analyst Ratings Have To Say About Apellis Pharmaceuticals
Tickers APLS
Tags Market News BZI/AAR Benzinga
From Benzinga
Analyst Expectations For Apellis Pharmaceuticals's Future
Tickers APLS
Tags Analyst Ratings Benzinga Market News
From Benzinga
Mama's Creations Posts Weak Earnings, Joins EVgo, Red Cat Holdings And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Tickers APLS CELC EVCM EVGO
Tags EVCM CELC Premarket Movers
From Benzinga
This Match Group Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Tickers ADC APLS COMM EXEL
Tags MTCH COMM Trading Ideas
From Benzinga
Deep Dive Into Apellis Pharmaceuticals Stock: Analyst Perspectives (20 Ratings)
Tickers APLS
Tags Analyst Ratings APLS BZI/AAR
From Benzinga
A Glimpse Into The Expert Outlook On Apellis Pharmaceuticals Through 20 Analysts
Tickers APLS
Tags Analyst Ratings Market News BZI/AAR
From Benzinga
Energizer, C3.ai, Insmed And Other Big Stocks Moving Higher On Tuesday
Tickers AI ALMS APLD APLS
Tags LUNR OSCR Market News
From Benzinga
Lululemon To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday
Tickers ACLX APLS BR CHH
Tags EMR analysts forecasts CMI
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.